# Pomerantz Law Firm

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/pomerantz-law-firm
Canonical HTML page: https://getbiobrief.com/entity/pomerantz-law-firm

## Timeline

- **2026-Q3**: Motion to Dismiss Phase — Defendants expected to file motions to dismiss based on Safe Harbor protections for forward-looking statements.
- **2026-04-15**: Lead Plaintiff Deadline (Est.) — Typical 60-day window for investors to petition the court to lead the consolidated class action.
- **2026-03-05**: Investor Alerts Issued — Pomerantz Law Firm releases multiple reminders for class action deadlines across the biotech sector.

## Recent coverage (2 stories)

### Aquestive Therapeutics Faces Legal Scrutiny Amid Earnings Miss and Insider Sales
2026-03-13 02:06:17 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued a formal reminder to Aquestive Therapeutics (AQST) investors regarding an ongoing class action lawsuit following a period of financial underperformance. The litigation coincides with a recent quarterly earnings miss and notable insider selling, creating a challenging regulatory and legal environment for the biotech firm.
Full story: https://getbiobrief.com/story/aquestive-therapeutics-legal-scrutiny-class-action

### Pomerantz Law Firm Issues Class Action Deadlines for Major Biotech Firms
2026-03-05 23:21:15 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Pomerantz Law Firm has issued urgent reminders to investors regarding class action deadlines for Ultragenyx, Mereo BioPharma, Navan, and Fermi. These legal actions follow allegations of misleading statements and failures to disclose material risks concerning clinical data and financial projections.
Full story: https://getbiobrief.com/story/pomerantz-biotech-class-action-deadlines-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.